These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37822312)

  • 1. The heated debate over NAFLD renaming: An ongoing saga.
    Yilmaz Y
    Hepatol Forum; 2023; 4(3):89-91. PubMed ID: 37822312
    [No Abstract]   [Full Text] [Related]  

  • 2. Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
    Lonardo A
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33572544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NAFLD-MAFLD debate: Eminence vs evidence.
    Fouad Y; Elwakil R; Elsahhar M; Said E; Bazeed S; Ali Gomaa A; Hashim A; Kamal E; Mehrez M; Attia D
    Liver Int; 2021 Feb; 41(2):255-260. PubMed ID: 33220154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's in a name? Renaming 'NAFLD' to 'MAFLD'.
    Fouad Y; Waked I; Bollipo S; Gomaa A; Ajlouni Y; Attia D
    Liver Int; 2020 Jun; 40(6):1254-1261. PubMed ID: 32301554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between renaming schizophrenia and stigma-related outcomes: A systematic review.
    Yamaguchi S; Mizuno M; Ojio Y; Sawada U; Matsunaga A; Ando S; Koike S
    Psychiatry Clin Neurosci; 2017 Jun; 71(6):347-362. PubMed ID: 28177184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NAFLD renaming to MAFLD, MASLD: background, similarities, differences, and countermeasures].
    Fan JG; Li XY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):789-792. PubMed ID: 37723058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors.
    Huang XJ; Yin M; Zhou BQ; Tan XY; Xia YQ; Qin CX
    World J Hepatol; 2023 Aug; 15(8):985-1000. PubMed ID: 37701916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study.
    Kemp W; Clayton-Chubb D; Majeed A; Glenister KM; Magliano DJ; Lubel J; Bourke L; Simmons D; Roberts SK
    J Gastroenterol Hepatol; 2022 Feb; 37(2):395-403. PubMed ID: 34693553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Debate over Japanese renaming of term for schizophrenia.
    Desapriya EB; Nobutada I
    Lancet; 2003 Jan; 361(9352):181. PubMed ID: 12531615
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of MAFLD and NAFLD Characteristics in Children.
    Xing Y; Fan J; Wang HJ; Wang H
    Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Adaptor Protein ENY2 Is a Component of the Deubiquitination Module of the Arabidopsis SAGA Transcriptional Co-activator Complex but not of the TREX-2 Complex.
    Pfab A; Bruckmann A; Nazet J; Merkl R; Grasser KD
    J Mol Biol; 2018 May; 430(10):1479-1494. PubMed ID: 29588169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renaming Schizophrenia and Stigma Reduction: A Cross-Sectional Study of Nursing Students in Taiwan.
    Chiu YH; Kao MY; Goh KK; Lu CY; Lu ML
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renaming schizophrenia: a Japanese perspective.
    Sato M
    World Psychiatry; 2006 Feb; 5(1):53-5. PubMed ID: 16757998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in newspaper coverage of schizophrenia in Japan over 20-year period.
    Aoki A; Aoki Y; Goulden R; Kasai K; Thornicroft G; Henderson C
    Schizophr Res; 2016 Aug; 175(1-3):193-197. PubMed ID: 27177807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management.
    Lonardo A; Arab JP; Arrese M
    Adv Ther; 2021 May; 38(5):2130-2158. PubMed ID: 33829368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in NAFLD: current areas of contention.
    Jennison E; Byrne CD
    Fac Rev; 2023; 12():10. PubMed ID: 37153139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renaming schizophrenia to reduce stigma: comparison with the case of bipolar disorder.
    Ellison N; Mason O; Scior K
    Br J Psychiatry; 2015 Apr; 206(4):341-2. PubMed ID: 25573395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Renaming Schizophrenia in Korea: from "Split-Mind Disorder" to "Attunement Disorder".
    Cho JW; Jang EY; Woo HJ; Park YC; Kim SH; Hong KS; Lee YS; Kwon JS
    Psychiatry Investig; 2018 Jul; 15(7):656-662. PubMed ID: 30032592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAFLD to MAFLD in adults but the saga continues in children: an opportunity to advocate change.
    Hegarty R; Singh S; Bansal S; Fitzpatrick E; Dhawan A
    J Hepatol; 2021 Apr; 74(4):991-992. PubMed ID: 33493527
    [No Abstract]   [Full Text] [Related]  

  • 20. The debate about renaming schizophrenia: a new name would not resolve the stigma.
    Gaebel W; Kerst A
    Epidemiol Psychiatr Sci; 2019 Jun; 28(3):258-261. PubMed ID: 30203732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.